峰会纪要:新发媒介传播病毒病的生物医学对策研发
新发和再发传染病对全球公共卫生、安全和经济构成日益扩大的威胁,人口增长、城市化、森林砍伐、气候变化、反疫苗运动、战争和国际旅行等因素推动这一趋势。近期埃博拉、MERS-CoV和寨卡疫情表明,我们在以验证安全有效的疫苗和治疗药物进行应对方面准备不足。
要点
- 新发和再发传染病威胁持续扩大,受人口增长、城市化、气候变化、国际旅行等多因素驱动。
- 埃博拉、MERS-CoV和寨卡疫情暴露全球在验证安全有效疫苗和治疗药物应对上的准备不足。
- 峰会汇集生命科学和生物医学研发领域专家,盘点能力、评估差距并探讨改进方向。
核心结论
- 近期埃博拉、MERS-CoV和寨卡疫情表明,全球尚不具备以验证安全有效的疫苗和治疗药物充分应对新发媒介传播病毒病的准备。
主要发现
- 新发和再发传染病对全球公共卫生、安全和经济构成日益扩大的威胁。
- 人口增长、城市化、森林砍伐、气候变化、反疫苗运动、战争和国际旅行是推动该趋势的部分因素。
- 峰会旨在探讨全球生物防备挑战、盘点准备与应对的现有能力和容量、评估当前差距并展望改进方向。
临床怎么用
- 预防医学与公共卫生工作者应关注新发媒介传播病毒病的生物医学对策研发进展,识别准备与应对的能力差距。
局限性
- 本文为峰会纪要,未报告原始研究数据或定量分析结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current "gaps," and prospect what could be done to improve our position. Herein we describe the summit proceedings, "Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases," held October 2-3, 2018, at the Trudeau Institute in Saranac Lake, NY.
引用
- Blackman MA, Marchionni MA, Gilly J, et al. Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases. Vaccine. 2019. PMID: 31500964. doi:10.1016/j.vaccine.2019.08.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。